neuranapharma.com

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-Agent: AdsBot-Google-Mobile User-Agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/*

Meta Tags

Title	OMZYA®
Description	American Society of Interventional Pain Physicians Meeting MUSCLE SPASMS OMZYA® CLINICAL DEVELOPMENT PUBLICATIONS COMPANY CAREERS NEWS + Use tab to navigate through the menu items. Open Site Navigation PUBLICATION
Keywords	N/A

Server Information

WebSite	neuranapharma.com
Host IP	185.230.63.186
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

neuranapharma.com Valuation

US$2,740,689

Last updated: 2022-07-09 05:44:13

neuranapharma.com has Semrush global rank of 3,861,914. neuranapharma.com has an estimated worth of US$ 2,740,689, based on its estimated Ads revenue. neuranapharma.com receives approximately 316,234 unique visitors each day. Its web server is located in -, with IP address 185.230.63.186. According to SiteAdvisor, neuranapharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,740,689
Daily Ads Revenue	US$2,530
Monthly Ads Revenue	US$75,896
Yearly Ads Revenue	US$910,752
Daily Unique Visitors	21,083
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
neuranapharma.com.	A	3598	IP: 185.230.63.186
neuranapharma.com.	A	3598	IP: 185.230.63.107
neuranapharma.com.	A	3598	IP: 185.230.63.171
neuranapharma.com.	NS	86400	NS Record: ns14.wixdns.net.
neuranapharma.com.	NS	86400	NS Record: ns15.wixdns.net.
neuranapharma.com.	MX	3600	MX Record: 0 neuranapharma-com.mail.protection.outlook.com.

HtmlToTextCheckTime:2022-07-09 05:44:13

MUSCLE SPASMS OMZYA® CLINICAL DEVELOPMENT PUBLICATIONS COMPANY CAREERS NEWS + Use tab to navigate through the menu items. Open Site Navigation PUBLICATIONS NEWS More than 60 Years of Use Outside the US OMZYA® in Clinical Development for Commercialization in the US HOW IT WORKS Sodium & Calcium Channel Blocking Mechanism Potential Dual Mechanism for Relief of Muscle Spasm New Chemical Entity (NCE) Composition of matter IP coverage to 2032 with possible patent term extension to 2037 Exclusive worldwide development and commercialization rights US Approved outside of the US since 1959 (24 countries) Primary indication: therapeutic treatment of post-stroke spasticity Widely used in parts of Europe, South America and Asia EX-US Tolperisone Overcame Hurdle to Seek Approval in the US (4-MMPPO as a degradant in the tolperisone used ex-US) American Society of Interventional Pain Physicians Meeting (ASIPP) Neurana’s CMO, Dr. Randall Kaye, MD, presents at the 23rd Annual ASIPP Meeting. The

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 30 Oct 2021 14:23:02 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.neuranapharma.com/
strict-transport-security: max-age=120
Age: 66715
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVho24eAEbfscWhcpKw1HIzZ,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6dGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalrH+iJydtFVv5/y1XincnCBg5jPOgEKHh5MnQ8rTyYGH7arCUxQfotUuTH+oxgi8/w==,2UNV7KOq4oGjA5+PKsX47DqQgZ4euQCNWDy58PBtjlYfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1635603782.700864086935130155
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Sat, 30 Oct 2021 14:23:03 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1635603782.94396768513914757
content-language: en
strict-transport-security: max-age=120
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMd0qnhlQ7CKiS1i9ukj0dSj,qquldgcFrj2n046g4RNSVFCyQoc+8a4IB0r6FC3J5Wc=,2d58ifebGbosy5xc+FRaltOywjf0W5dErSmBUaQdWDbBJ4bMpVGPUBJu+co/8Jm7Sf524lPwTgDbn82fURSkbhzpqaSPDnTVeYhhgijRN6w=,2UNV7KOq4oGjA5+PKsX47MuWjC1KFhNR/NziahEGFwtYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,qJS91GsscGZlb16v+8nwmI0CUxhe4FVRn5l7JPiPU84PUN6zYCeYUhP+LoeE7OiY,wjXkXN74v+Dcwxj+Ualvvv1rWrJ1uVExjVcH1Sv0v0iOo/FgjVBbL9h0vKXAJ/s6BFNjNRTmQgt5BwMmIVG00A==,qJS91GsscGZlb16v+8nwmI0CUxhe4FVRn5l7JPiPU84PUN6zYCeYUhP+LoeE7OiY,LoUK8/saGAmOxZWtpubo2oL0+k1UdVRmz30uCOJ2so0shMKtkS4Wr4REh/6FBUZcFyeCTCc8MXGC1cvHBH32pQ==,gZE4V9HjxqLIHwGwkmiVcPwGp/YAOo15MvXxso7J9dsaWyug/ZdHQ36uOAkr89T0,qJS91GsscGZlb16v+8nwmD0c15HnOCXM0+/ZxvRA4lIPUN6zYCeYUhP+LoeE7OiY,/a5ccLSK1HEmwPNg/x6Ousi+IhBxyxtCO3cAQz98jWuP8vKXODZMiQyshrsWE/x97ncgEhfe9IHJQmxpDKYlbA==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=usc1_g; Max-Age=20; Expires=Sat, 30 Oct 2021 14:23:23 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=usc1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

neuranapharma.com Whois Information

Domain Name: NEURANAPHARMA.COM
Registry Domain ID: 1777399639_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2019-12-01T08:53:45Z
Creation Date: 2013-01-31T01:02:56Z
Registry Expiry Date: 2022-01-31T01:02:56Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS14.WIXDNS.NET
Name Server: NS15.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T00:40:07Z <<<

neuranapharma.com valuation and analysis